|
EP2116525A1
|
|
Process for the preparation of tigecycline in the amorphous form
|
|
EP2070537A1
|
|
Crystalline polymorphs of topotecan hydrochloride and methods for the preparation thereof
|
|
US2009036672A1
|
|
Intermediate cefdinir salts
|
|
EP1903051A2
|
|
Epoxidation of 17-oxo-15,16-methylene steroids with sulfoxonium ylides
|
|
KR20080039970A
|
|
Purification of tacrolimus on supports of vegetable origin
|
|
CA2588268A1
|
|
Crystalline from of cefdinir ammonium salt as an intermediated for the preparation of pure cefdinir
|
|
US2008160586A1
|
|
Process for the Purification of Tacrolimus
|
|
EP1602654A1
|
|
Process for the synthesis of thalidomide
|
|
EP1553175A1
|
|
Cephalosporin C acylase mutants
|
|
AU2003293746A1
|
|
Crystalline cefdinir salts
|
|
AU2003293585A1
|
|
Intermediate cefdinir salts
|
|
US7019140B2
|
|
Process for the synthesis of pergolide
|
|
CN1585758A
|
|
A process for the preparation of cephalosporins side chains
|
|
KR20050035178A
|
|
A process for the preparation of cefixime via alkyl-or aryl-sulfonates
|
|
WO03024977A1
|
|
Process for the preparation of crystalline cefuromixe axetil
|
|
WO03014126A1
|
|
Process for the preparation of highly pure cefuroxime axetil
|
|
AU6593901A
|
|
A process for the preparation of anthracycline derivatives
|
|
WO0179210A2
|
|
A process for the preparation of highly crystalline sodium cefoperazone
|
|
CN1364169A
|
|
Process for the synthesis of beta-lactam derivatives
|
|
EP1178991A1
|
|
A process for the preparation of beta-lactam derivatives
|
